skip navigation Go to main menu

Respecta® [Probiotics Complex]

respecta
Type
MFDS Approval (No. 2019-26)
Daily dose
124.35 mg / day (5 x 10 9 CFU)
Functionality
Proliferation of vaginal beneficial flora to suppress pathogenic bacteria
    • L. acidophilus  LA-14®  :  Sterilization of harmful bacteria and adhesion in the vagina
    • L. rhamnosus  HN001®  :  Inhibition of adhesion and proliferation of harmful bacteria
    • Lactoferrin  : Immunomodulators, Prebiotics
    • After two weeks of intake,
      an increase in the number of
      beneficial vaginal bacteria
      was
      confirmed even after seven days
      of stopping intake
    • Confirmed the effect of improving
      female vaginitis in four cases of
      human clinical studies.
    • Guarantee 5 billion CFU per day
Vaginal Health

Vaginitis, also called a woman's cold, refers to inflammation caused when the immunity of women’s bodies weakens due to overwork, stress, and nutrient imbalance, which leads to a break-down of the natural acidity in the vagina, making it easier for bacteria and viruses to invade the vagina. In general, antibiotic treatment is often required when vaginitis occurs. However, since antibiotic treatment eliminates not only bacteria and viruses but also beneficial bacteria in women's bodies, it may be difficult to resolve the fundamental cause of weakened immunity. Rather, long-term use of antibiotics may cause chronic vaginitis. Therefore, even when you have vaginitis, it is important to strengthen your immunity and create an environment in which beneficial bacteria in your vagina can thrive. Respecta helps create a healthy vaginal environment by enabling the proliferation of beneficial vaginal bacteria and suppressing harmful bacteria. If you manage your vaginal health through Respecta, the quality of your life improves by alleviating the symptoms of vaginitis.

Key features

  • Optimal combination of patented probiotics and premium bovine lactoferrin
  • Effect of suppressing the adhesion and proliferation of harmful bacteria
  • Confirmed the effect of suppressing the expression of inflammation-causing factors in the vagina
  • Confirmed immediate effect by improving vaginitis through intake of 15 days
  • Confirmed improvement in vaginal symptoms such as vaginal itching, vaginal discharge, and fishy odor
  • Uses raw materials proven to be safe through GRAS
  • Patents registered (US, EU)

Formulation

  • Hard Capsule

  • Powder

Research Results

  • 4 human clinical studies completed
    Ⅰ:정상인 Ⅱ:반건강인 Ⅲ:세균성 질염 환자 Ⅳ:캔디다성 질염 환자
  • Main results of human clinical studies
    • Vaginal L.acidophilus and L.rhamnosus levels were significantly increased compared to baseline.
    • Nugent score was significantly improved in Respecta group compared to baseline and placebo group.
    • Vaginal symptoms (itching and vaginal discharge) were significantly improved in Respecta group compared to baseline and placebo group.
    • Respecta improved the clinical overall cure rate and reduced recurrence rate of bacterial vaginosis and vulvovaginal candidiasis.